Skip to content

The effect of compassion therapy on emotional repression and perception of suffering of female patients with vitiligo.

The effectiveness of treatment on compassion in reducing emotional repression and Perception of the suffering of women with vitiligo undergoing phototherapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220403054398N1
Enrollment
40
Registered
2022-10-30
Start date
2022-11-21
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Vitiligo. Condition 2: Perception of Suffering. Condition 3: Emotional Repression. Vitiligo

Interventions

Intervention 1: The intervention group of compassion-focused therapy had 8 sessions as two 90-minute sessions in four consecutive weeks, which used techniques (such as: meditation and recognition of e
Evaluating the amount of emotional abuse, describing and explaining emotional abuse and factors related to its symptoms and conceptualizing self-compassion training. Second session: Mindfulness traini
Teaching to understand how people feel to follow things with an empathic attitude and homework. The third session: getting to know the characteristics of people with compassion, compassion towards
and providing homework. The fourth session: reviewing the exercise of the previous session, encouraging the subjects to self-identify and examine their personality as a "compassionate" or "n

Sponsors

Tehran University of Medical Sciences
Lead Sponsor
Shahab Danesh University.
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Vitiligo diagnosis by the attending physician is a condition for entering the study. The age range between 18 and 40 years is the condition for entering the study. Female gender is a condition for entering the study.

Exclusion criteria

Exclusion criteria: The use of psychiatric drugs is not included in the study. Co-occurring with vitiligo is a reason not to enter the study. Suffering from psychiatric diseases is the reason for not entering the study.

Design outcomes

Primary

MeasureTime frame
The score of the Weinberger Adaptability Questionnaire (WAI) . Timepoint: Before the start of the intervention, after the end of the intervention, one month after the end of the intervention. Method of measurement: Weinberger Adaptability Questionnaire (WAI).;The score of the Scholz Suffering Questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention, one month after the end of the intervention. Method of measurement: Scholz Suffering Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZainab Aryanian

Tehran University of Medical Sciences

z_aryanian@yahoo.com+98 21 5563 0553

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026